Airtel Q4 Net Profit at Rs 759 Crore Growing Domestic Business

Bharti Airtel reported strong fourth quarter revenue growth due to increase in domestic connections

Telecom giant Bharti Airtel reported a consolidated net profit of Rs 759 crore for the period ended March 31, 2021, attributing strong customer growth and a major boom in the domestic business segment, mainly due to the country’s many There is corona virus induced lockdown in parts. country.

Its revenue from operations for the March quarter rose 12 percent to Rs 25,747 crore. It was Rs 23,018 crore in the year-ago period.

The company had a loss of Rs 5,237 crore during the same period of FY15.

Revenue from India’s business grew 17.5 percent year-on-year to Rs 18,338 crore, while revenue from mobile services grew by 19.1 percent year-on-year, the company said.

Airtel’s consolidated EBITDA for the quarter under review stood at Rs 12,583 crore, while EBITDA margin came in at 48.9 percent – a year-on-year improvement of 647 bps.

Mobile average revenue per user (ARPU) during the March quarter stood at Rs 145 compared to Rs 135 in the same period of FY15 on a comparable basis.

“The relentless focus on customer passion that has allowed us to deliver another consecutive quarter in terms of performance. Our mobile revenue grew by 19.1 percent supported by 13.7 million 4G customer additions. We net 274,000 in our domestic business Gopal Vittal, managing director and CEO of Bharti Airtel, said, “The enterprise segment grew in double digits. Our digital assets are continuously growing and we start seeing strong traction in monetization of these assets.” are doing.

Commenting on the challenges posed by the second wave of coronaviruses, Mr. Vitthal said, “We recognize the importance of our role as a telecom operator in keeping our customers and the nation connected at such times. Our focus is uninterrupted services and great Providing. The end user experience while ensuring the safety of our employees and partners. “

.

LEAVE A REPLY

Please enter your comment!
Please enter your name here